Unlocking Opportunities in the Single-Cell Omics Market: 2025-2034 Forecast Report

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Single-Cell Omics Industry Market Size Be by 2025?
In the recent past, the single-cell omics market has seen a swift expansion. The market size is forecasted to surge from $2.08 billion in 2024 up to $2.41 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 15.9%. Factors contributing to this growth during the historical period include the discovery of cellular heterogeneity, the development of single-cell analysis tools, advancements in biomedical research, the characterization of the immune system, and the growing prominence of precision medicine.

What's the Long-Term Growth Forecast for the Single-Cell Omics Market Size Through 2029?
Anticipations are high for a swift expansion in the single-cell omics market over the coming years. The market is projected to appreciate to $4.52 billion by 2029 with a compound annual growth rate (CAGR) of 17.0%. The surge in this epoch can be credited to its acceptance in diagnostics and clinical applications, unification with multi-omics approaches, usage in revitalizing medicine, drug development and discovery, cellular treatments, and immunotherapies. Key trends anticipated during this period encompass studies of in vivo single-cell, single-cell omics applied in infectious disease research, microfluidics integrated with single-cell sorting, the integration of single-cell multi-omics, and spatial single-cell characterizing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

What Are the Key Growth Drivers Fueling the Single-Cell Omics Market Expansion?
The escalating cases of cancer are anticipated to drive the expansion of the single-cell omics market in the future. Cancer, a group of diseases characterized by uncontrolled growth and spread of abnormal cells, can develop almost anywhere in the human body. These cells often breach their normal boundaries, spreading to other organs or infiltrating nearby parts of the body. The identification of cancer biomarkers for diagnosis and prognosis estimation, along with the exploration of new therapeutic targets within predefined clinical cohorts, has greatly benefited from the application of single-cell omics data. For example, data from the National Institutes of Health, a US government agency, shows that as of January 2022, there were an estimated 18.1 million cancer survivors in the US. This figure is projected to reach 22.5 million by 2032. Hence, the increasing incidence of cancer is fueling the expansion of the single-cell omics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Are the Key Trends Driving Single-Cell Omics Market Growth?
One key trend growing in prominence in the single-cell omics market is product innovation. The market's leading companies are creating unique products to maintain their market stance. For example, Deepcell, a US organization specializing in single-cell dimensional morphology analysis software development, introduced the REM-I Platform in May 2023. This scalable single-cell imaging platform offers high-dimensional analysis, cell sorting, and unprecedented insights into cell biology. The REM-I Platform is likely to spur discoveries in multiple areas, including cancer biology, stem cell biology, gene therapy, developmental biology, functional screening, etc., by merging single-cell imaging, sorting, and high-dimensional analysis.

How Is the Single-Cell Omics Market Segmented?
The single-cell omics market covered in this report is segmented -

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics
2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing
3) By Application: Oncology, Cell Biology, Neurology, Immunology
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:
1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits
2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits
3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits
4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

Which Companies Are Leading the Charge in Single-Cell Omics Market Innovation?
Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton dic*kinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Which Regions Are Leading the Global Single-Cell Omics Market in Revenue?
North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.